Cytek Biosciences, Inc. CTKB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$74M-11.2% | -$66.54M— | —— | —— | —— | ||
| $7.57M-0.1% | $7.58M+0.6% | $7.54M+0.9% | $7.47M+1.1% | $7.39M+2.4% | ||
| $22.82M-7.2% | $24.59M-5.7% | $26.06M-5.1% | $27.48M-1.3% | $27.84M+3.7% | ||
| -$7.41M-54.5% | -$4.79M-137% | -$2.03M-113% | $15.09M-29.1% | $21.3M-16.1% | ||
| $5.4M+32.3% | $4.08M+2.7% | $3.98M-8.2% | $4.33M+13.8% | $3.81M+8.0% | ||
| —— | —— | -$51.47M+40.3% | -$86.2M-23.5% | -$69.79M+17.9% | ||
| —— | —— | —— | $34.09M+5.7% | $32.25M+49.2% | ||
| $9.96M+78.4% | $5.58M-19.7% | $6.95M+42.9% | $4.87M+39.8% | $3.48M-16.8% | ||
| $4.1M-13.7% | $4.75M+144% | $1.94M+0.3% | $1.94M+0.2% | $1.94M+248% | ||
| —— | —— | —— | -$29.87M-3.1% | -$28.98M-83.2% | ||
| —— | —— | —— | -$102.45M-38.7% | -$73.84M-7.2% | ||
| -$12.7M-44.8% | -$8.77M-48.8% | -$5.9M-154% | $10.87M-37.9% | $17.49M-20.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cytek Biosciences, Inc. generate?
- Cytek Biosciences, Inc. (CTKB) generated -$7.4M in operating cash flow over the trailing twelve months.
- What is Cytek Biosciences, Inc.'s free cash flow?
- After $5.4M of capital expenditures, Cytek Biosciences, Inc.'s free cash flow was -$12.7M over the trailing twelve months, down 172.6% year over year.
- Where does Cytek Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Cytek Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
